ARTICLE
|
doi:10.20944/preprints202309.0619.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
acute lymphoblastic leukemia; imatinib; dasatinib: nilotinib; ponatinib; blinatumomab; reducedintensity chemotherapy; chemotherapy-free; progression-free
Online: 11 September 2023 (04:05:57 CEST)
ARTICLE
|
doi:10.20944/preprints202307.0060.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
acute lymphoblastic leukemia; imatinib; ponatinib; dasatinib; nilotinib; blinatumomab; reduced-intensity chemotherapy; chemotherapy-free; progression-free
Online: 7 July 2023 (14:32:15 CEST)
REVIEW
|
doi:10.20944/preprints202210.0008.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
relapsed-refractory multiple myeloma; overall survival; CAR-T; non CAR-T agents
Online: 3 October 2022 (12:16:01 CEST)